BUFFALO GROVE, Ill. -- Akorn today announced that the U.S. Food and Drug Administration (FDA) has granted approval for Akorn’s Abbreviated New Drug Application (ANDA) for Ofloxacin Ophthalmic ...
BUFFALO GROVE, Ill. — Akorn's abbreviated new drug application for ofloxacin ophthalmic solution 0.3% has been approved by the U.S. Food and Drug Administration, the company announced in a press ...
Ofloxacin Ophthalmic Solution USP 0.3% is indicated for the treatment of eye infections caused by the conditions of conjunctivitis and corneal ulcers. According to IQVIATM (IMS Health), Ofloxacin ...
https://www.thehindubusinessline.com/markets/caplin-point-labs-subsidiary-gets-usfda-approval-for-ofloxacin-otic-solution-03/article67718608.ece Copy Caplin Point ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. NEW ORLEANS — Applying topical ofloxacin preoperatively ...
https://www.thehindubusinessline.com/markets/stock-markets/caplin-point-laboratories-subsidiary-gets-anda-approval-for-eye-drops-solution/article68070831.ece Copy ...